Burke Medical Research Institute   Report issue

Academic/Hospital Phase 2
Founded: White Plains NY United States (1915)

Organization Overview

First Clinical Trial
2014
NCT02292238
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2020

Timeline

NOW
  • Now

Alternative names

Burke Medical Research Institute

Active Ingredients

Drugs in Phase 2 Trials (1)

thiamine (1 trial)

Drugs in Other Trials (1)

escitalopram (lexapro) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Alzheimer Disease (Phase 2)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 2
  • # of Trial APIs: 2